Satyanarayana Ande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Satyanarayana Ande has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Barrett
Department of Pathology, Medical College of Georgia, Augusta University, Augusta, Georgia
37 shared publications - Anatolij Horuzsko
Georgia Cancer Center, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States
37 shared publications - Caixia Xi
Georgia Cancer Center, Augusta University, Medical College of Georgia 1 Department of Radiation Oncology Augusta, GA
37 shared publications - Junfeng Pang
Georgia Cancer Center, Augusta University 3 , Augusta, GA
37 shared publications - Nahid F. Mivechi
Augusta University
37 shared publications - Xingguo Zhu
Georgia Cancer Center, Augusta University, Augusta, USA
37 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S7. Nrf2 suppression decreases liver tumor progression.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S7. Nrf2 suppression decreases liver tumor progression.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S6. A glucose dependency of NRF2 regulation in HepG2 cells.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S6. A glucose dependency of NRF2 regulation in HepG2 cells.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplemental Table 1. DNA Oligos
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplemental Table 1. DNA Oligos
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplementary Figure 4. NRF2 silencing shows no effect on histone acetylation or acetyl-CoA.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplementary Figure 4. NRF2 silencing shows no effect on histone acetylation or acetyl-CoA.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S2. Nrf2 ablation affects gene expression in mouse liver tumors.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S2. Nrf2 ablation affects gene expression in mouse liver tumors.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S8. GCK and ALDOA gene expression in glucose-deprived shNRF2 HepG2 cells after energy-refeeding.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S8. GCK and ALDOA gene expression in glucose-deprived shNRF2 HepG2 cells after energy-refeeding.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S5. Hypoxia shows no contribution to the NRF2 regulated histone acetylation.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S5. Hypoxia shows no contribution to the NRF2 regulated histone acetylation.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental material and methods from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplemental material and methods
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental material and methods from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
Supplemental material and methods
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S9. MYC silencing reduced the expression of glycolysis genes in HepG2 cells.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S9. MYC silencing reduced the expression of glycolysis genes in HepG2 cells.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S3. Nrf2 ablation shows no effect on the levels of acetyl-CoA or CoASH in tumor adjacent liver tissues.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
S3. Nrf2 ablation shows no effect on the levels of acetyl-CoA or CoASH in tumor adjacent liver tissues.